Point72 DIFC Ltd Acquires New Position in Enhabit, Inc. (NYSE:EHAB)

Point72 DIFC Ltd bought a new position in shares of Enhabit, Inc. (NYSE:EHAB) during the 3rd quarter, Holdings Channel reports. The firm bought 13,733 shares of the company’s stock, valued at approximately $108,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Gladius Capital Management LP purchased a new stake in Enhabit during the second quarter worth $31,000. Quarry LP grew its holdings in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares during the last quarter. Stoneridge Investment Partners LLC purchased a new position in shares of Enhabit in the third quarter valued at $81,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Enhabit during the 2nd quarter worth $93,000.

Enhabit Stock Down 3.3 %

Shares of NYSE:EHAB opened at $7.73 on Monday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $388.66 million, a P/E ratio of -3.33 and a beta of 1.89. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.74. The stock’s fifty day simple moving average is $7.46 and its 200-day simple moving average is $8.31.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the business earned $0.03 earnings per share. As a group, equities research analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Leerink Partners reissued a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $9.25.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.